← ANALYST RATINGS · TIPRANKS
Irhythm Technologies (IRTC): analyst forecast and price target
Analyst consensus
Strong Buy7 Buy0 Hold0 Sell
Ratings of 7 analysts in the last 3 months · top analysts only12-month forecast
Based on 7 price targets given in the last 3 months, the average target is $177, the highest $196, the lowest $160. The average is +62.7% from the last price of $109.
Analyst ratings 20
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Adam Maeder★★★★★★★★★★#1026 · hits 54% · avg +11.3% | Piper Sandler | $160 | Buy | +47.2% | Initiated | 16.10.26on TipRanks 04:50 | +0.5% | ↗ |
| Nathan Treybeck★★★★★★★★★★#10843 · hits 28% · avg −5.3% | Wells Fargo | $168 → $150−10.7% | Buy | +38.0% | Reiterated | 06.10.26on TipRanks 06:10 | −2.3%next day −1.8% · 5 days +0.6% | ↗ |
| William Plovanic★★★★★★★★★★#5377 · hits 43% · avg +1.3% | Canaccord Genuity | $196 | Buy | +80.4% | Reiterated | 05.10.26on TipRanks Oct 6 07:45 | −1.8%next day −2.3% · 5 days −2.6% | ↗ |
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $114 → $112−1.8% | Hold | +3.1% | Reiterated | 05.10.26on TipRanks 16:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $111 → $112+0.9% | Hold | +3.1% | Reiterated | 05.10.26on TipRanks 16:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $112 → $113+0.9% | Hold | +4.0% | Reiterated | 05.10.26on TipRanks 16:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $117 → $119+1.7% | Hold | +9.5% | Reiterated | 05.10.26on TipRanks 16:05 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $110 → $113+2.7% | Hold | +4.0% | Reiterated | 05.10.26on TipRanks 16:05 | — | |
| David Saxon★★★★★★★★★★#6662 · hits 38% · avg +0.8% | Needham | $192 → $194+1.0% | Buy | +78.5% | Reiterated | 05.10.26on TipRanks 10:11 | −1.8%next day −2.3% · 5 days −2.6% | ↗ |
| Nathan Treybeck★★★★★★★★★★#10843 · hits 28% · avg −5.3% | Wells Fargo | $168 | Buy | +54.6% | Reiterated | 24.09.26on TipRanks 16:30 | −0.9%next day +2.8% · 5 days +0.2% | ↗ |
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $115 → $114−0.9% | Hold | +4.9% | Reiterated | 23.09.26on TipRanks 00:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $116 | Hold | +6.8% | Reiterated | 23.09.26on TipRanks 00:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $116 → $111−4.3% | Hold | +2.2% | Reiterated | 23.09.26on TipRanks 00:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $110 → $112+1.8% | Hold | +3.1% | Reiterated | 23.09.26on TipRanks 00:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $119 → $117−1.7% | Hold | +7.7% | Reiterated | 23.09.26on TipRanks 00:05 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $116 → $110−5.2% | Hold | +1.2% | Reiterated | 23.09.26on TipRanks 00:05 | — | |
| Brandon Vazquez★★★★★★★★★★#11688 · hits 42% · avg −5.1% | William Blair | — | Buy | — | Reiterated | 04.09.26on TipRanks 05:05 | +0.1%next day −0.1% · 5 days −5.6% | ↗ |
| William Plovanic★★★★★★★★★★#5377 · hits 43% · avg +1.3% | Canaccord Genuity | $212 → $196−7.5% | Buy | +80.4% | Reiterated | 27.08.26on TipRanks 07:15 | −3.0%next day +3.6% · 5 days +5.8% | ↗ |
| Eugene Mannheimer★★★★★★★★★★#3417 · hits 51% · avg +6.8% | Freedom Capital Markets | $200 → $190−5.0% | Buy | +74.9% | Reiterated | 20.08.26on TipRanks Sep 27 04:50 | +3.4%next day 0.0% · 5 days −10.2% | ↗ |
| Richard Newitter★★★★★★★★★★#1772 · hits 48% · avg +6.6% | Truist Financial | — | Buy | — | Reiterated | 19.08.26on TipRanks 07:35 | +8.0%next day +3.4% · 5 days −4.1% | ↗ |
| Stephanie Elghazi★★★★★★★★★★#8552 · hits 50% · avg +2.3% | Bank of America Securities | — | Buy | — | Reiterated | 14.08.26on TipRanks 11:15 | +2.9%next day −7.1% · 5 days +3.0% | ↗ |
| Joanne Wuensch★★★★★★★★★★#3684 · hits 55% · avg +2.3% | Citi | $157 | Buy | +44.5% | Reiterated | 13.08.26on TipRanks 06:55 | −2.4%next day +2.9% · 5 days +5.9% | ↗ |
| Suraj Kalia★★★★★★★★★★#1646 · hits 50% · avg +6.8% | Oppenheimer | $185 | Buy | +70.3% | Assigned | 10.08.26on TipRanks Aug 7 08:20 | −0.8%next day −2.4% · 5 days −1.5% | ↗ |
| Vijay Kumar★★★★★★★★★★#2375 · hits 54% · avg +4.8% | Evercore ISI | $150 → $165+10.0% | Buy | +51.8% | Reiterated | 07.08.26on TipRanks 08:15 | −0.8%next day −2.4% · 5 days −1.5% | ↗ |
| David Rescott★★★★★★★★★★#3448 · hits 49% · avg +5.1% | Robert W. Baird | $160 → $165+3.1% | Buy | +51.8% | Reiterated | 07.08.26on TipRanks 08:00 | −0.8%next day −2.4% · 5 days −1.5% | ↗ |
| David Saxon★★★★★★★★★★#6662 · hits 38% · avg +0.8% | Needham | $255 → $192−24.7% | Buy | +76.7% | Reiterated | 07.08.26on TipRanks 07:15 | −0.8%next day −2.4% · 5 days −1.5% | ↗ |
| Marie Thibault★★★★★★★★★★#12343 · hits 40% · avg −9.7% | BTIG | $185 | Buy | +70.3% | Reiterated | 07.08.26on TipRanks 07:10 | −0.8%next day −2.4% · 5 days −1.5% | ↗ |
| Mason Carrico★★★★★★★★★★#10833 · hits 38% · avg −4.7% | Stephens | $160 | Buy | +47.2% | Initiated | 22.07.26on TipRanks Jul 27 06:32 | −2.6%next day +2.7% · 5 days +17.8% | ↗ |
| Allen Gong★★★★★★★★★★#2251 · hits 46% · avg +14.7% | J.P. Morgan | $215 → $175−18.6% | Buy | +61.1% | Reiterated | 01.05.26on TipRanks 08:40 | −6.7%next day −1.0% · 5 days −2.5% | ↗ |
| David Roman★★★★★★★★★★#3715 · hits 53% · avg +5.3% | Goldman Sachs | $147 | Hold | +35.3% | Reiterated | 30.04.26on TipRanks May 1 08:12 | +6.0%next day −6.7% · 5 days −5.1% | ↗ |
| Patrick Wood★★★★★★★★★★#10768 · hits 50% · avg −2.1% | UBS | $195 → $205+5.1% | Buy | +88.7% | Reiterated | 02.12.25on TipRanks 06:45 | −0.7%next day +0.3% · 5 days −4.8% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Irhythm Technologies
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $176 at a price of $114 (+55.1%); now: $173 at $109 (+59.5%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 3 |
| Buy | 8 | 10 | 10 | 10 | 8 | 7 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 05.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.01 (from $-0.16 to $0.27). Last quarter: $-0.01.
Sales
Next quarter’s sales estimate — $222M (from $222M to $223M). Last quarter: $224M.
Best top-analyst consensus in the sector · Healthcare
About Irhythm Technologies
- CEO: Quentin S. Blackford
- Employees: 2,400
- 699 8th Street, San Francisco, CA, 94103, US
- www.irhythmtech.com
iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.
Data from the stock’s TipRanks forecast page, read 28 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗